In yesterday’s Wall Street session, Kenvue Inc (NYSE:KVUE) shares traded at $19.10, down -0.26% from the previous session.
14 analysts cover Kenvue Inc (NYSE:KVUE), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $27.00 and a low of $20.00, we find $25.00. Given the previous closing price of $19.15, this indicates a potential upside of 30.55 percent. KVUE stock price is now -5.29% away from the 50-day moving average and -17.65% away from the 200-day moving average. The market capitalization of the company currently stands at $36.57B.
The stock has received a hold rating from 5 analysts and a buy rating from 7. Brokers who have rated the stock have averaged $24.00 as their price target over the next twelve months.
With the price target maintained at $27, Deutsche Bank recently Upgraded its rating from Hold to Buy for Kenvue Inc (NYSE: KVUE).
In other news, ALLISON RICHARD E JR, Director bought 5,598 shares of the company’s stock on Aug 30. The stock was bought for $128,524 at an average price of $22.96. Upon completion of the transaction, the Director now directly owns 25,598 shares in the company, valued at $0.49 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 11, Director ALLISON RICHARD E JR bought 20,000 shares of the business’s stock. A total of $525,232 was incurred on buying the stock at an average price of $26.26. This leaves the insider owning 20,000 shares of the company worth $0.38 million. Insiders disposed of 1,533,830,450 shares of company stock worth roughly $29.3 billion over the past 1 year. A total of 9.62% of the company’s stock is owned by insiders.
On Monday morning Kenvue Inc (NYSE: KVUE) stock kicked off with the opening price of $19.15. During the past 12 months, Kenvue Inc has had a low of $17.82 and a high of $27.80. As of last week, the company has a debt-to-equity ratio of 0.77, a current ratio of 1.14, and a quick ratio of 0.78. The fifty day moving average price for KVUE is $20.17 and a two-hundred day moving average price translates $23.19 for the stock.
The latest earnings results from Kenvue Inc (NYSE: KVUE) was released for Sep, 2023. According to the Household & Personal Products Company, earnings per share came in at $0.31, inline with analysts’ expectations of $0.31. This compares to $0.34 EPS in the same period last year. The company reported revenue of $3.92 billion for the quarter, compared to $3.79 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 3.33 percent. For the current quarter, analysts expect KVUE to generate $3.8B in revenue.
Kenvue Inc(KVUE) Company Profile
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women’s health, and wound care products under the Listerine, Johnson’s, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.